Warning: The NCBI web site requires JavaScript to function. more...
Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).
Talaulikar D, Shadbolt B, Dahlstrom JE, McDonald A.
J Hematol Oncol. 2009 Nov 22;2:49.
Related citations
Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations.
Talaulikar D, Dahlstrom JE.
Pathology. 2009;41(3):214-22. Review.
Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
Talaulikar D, Dahlstrom JE, Shadbolt B, McNiven M, Broomfield A, Pidcock M.
Pathology. 2007 Dec;39(6):580-5.
Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL).
Talaulikar D, Dahlstrom JE, Shadbolt B, Broomfield A, McDonald A.
J Histochem Cytochem. 2008 Oct;56(10):893-900. Epub 2008 Jun 23.
Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
Talaulikar D, Shadbolt B, Bell J, Khan K, Dahlstrom JE, McDonald A, Pidcock M, Broomfield A.
Histopathology. 2008 Feb;52(3):340-7.
[T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].
Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Luo XL.
Zhonghua Bing Li Xue Za Zhi. 2005 Dec;34(12):771-5. Chinese.
Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
Intragumtornchai T, Rotnakkarin P, Sutcharitchan P, Wannagrairoj P.
Clin Lymphoma. 2003 Jun;4(1):52-5.
Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders.
Kremer M, Spitzer M, Mandl-Weber S, Stecker K, Schmidt B, Höfler H, Quintanilla-Martínez L, Fend F.
Lab Invest. 2003 Jan;83(1):107-14.
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, Mitterbauer M, Skrabs C, Chott A, Simonitsch-Klupp I, Gleiss A, Lechner K, Jaeger U.
Leukemia. 2004 Jun;18(6):1102-7.
A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M, Ross CW, Hsi ED.
Histopathology. 2000 Jul;37(1):10-8.
Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.
Tomita N, Takeuchi K, Hyo R, Hashimoto C, Takemura S, Taguchi J, Fujita H, Fujisawa S, Ogawa K, Motomura S, Ishigatsubo Y.
Acta Haematol. 2009;121(4):196-201. Epub 2009 May 26.
Prognosis of localized diffuse large B-cell lymphoma in younger patients.
Møller MB, Christensen BE, Pedersen NT.
Cancer. 2003 Aug 1;98(3):516-21.
Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C, Acebedo G, Navarrete M, Ruiz-Marcellán C, Sanchez C, Blanco A, López A.
Haematologica. 2001 Sep;86(9):934-40.
Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.
Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS.
Blood. 2002 Feb 15;99(4):1136-43.
Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.
Chung R, Lai R, Wei P, Lee J, Hanson J, Belch AR, Turner AR, Reiman T.
Blood. 2007 Aug 15;110(4):1278-82. Epub 2007 May 2.
The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ.
Biol Blood Marrow Transplant. 2007 Apr;13(4):486-92. Epub 2007 Feb 15.
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, Gaillard F, Gastinne T, Milpied N, Moreau P, Harousseau JL, Avet-Loiseau H.
Haematologica. 2007 Oct;92(10):1335-42.
Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST.
Ann Hematol. 2009 May;88(5):417-24. Epub 2008 Sep 7.
Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.
Veelken H, Vik Dannheim S, Schulte Moenting J, Martens UM, Finke J, Schmitt-Graeff A.
Ann Oncol. 2007 May;18(5):931-9. Epub 2007 Mar 29.
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Nicolaides C, Fountzilas G, Zoumbos N, Skarlos D, Kosmidis P, Pectasides D, Karabelis A, Giannakakis T, Symeonidis A, Papadopoulos A, Antoniou F, Pavlidis N.
Oncology. 1998 Sep-Oct;55(5):405-15.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on